Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells

MLA

Yanjiao Ou, et al. “Targeting Antisense LncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.” Frontiers in Medicine, vol. 8, Apr. 2021. EBSCOhost, https://doi.org/10.3389/fmed.2021.649279.

APA

Yanjiao Ou, Yong Deng, Hong Wang, Qingyi Zhang, Huan Luo, & Peng Hu. (2021). Targeting Antisense lncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.649279

Chicago

Yanjiao Ou, Yong Deng, Hong Wang, Qingyi Zhang, Huan Luo, and Peng Hu. 2021. “Targeting Antisense LncRNA PRKAG2-AS1, as a Therapeutic Target, Suppresses Malignant Behaviors of Hepatocellular Carcinoma Cells.” Frontiers in Medicine 8 (April). doi:10.3389/fmed.2021.649279.